C

Choom Holdings Inc
CNSX:CHOO

Watchlist Manager
Choom Holdings Inc
CNSX:CHOO
Watchlist
Price: 0.005 CAD
Market Cap: 2.3m CAD

Relative Value

There is not enough data to reliably calculate the relative value of CHOO.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CHOO Relative Value
Base Case
Not Available
C
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0.1
Median 5Y
0.1
Industry
2.6
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-0.1
Industry
21.7
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-3.7
Industry
16.6
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
22.5
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-0.8
Industry
2.3
vs History
vs Industry
Median 3Y
1
Median 5Y
1
Industry
2.9
vs History
vs Industry
Median 3Y
2.5
Median 5Y
2.5
Industry
5.5
vs History
vs Industry
Median 3Y
-9
Median 5Y
-9
Industry
13.1
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.7
Industry
16.6
vs History
vs Industry
Median 3Y
-29.1
Median 5Y
-29.1
Industry
15.8
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-9.6
Industry
19.1
vs History
vs Industry
Median 3Y
1
Median 5Y
1
Industry
1.9

Multiples Across Competitors

CHOO Competitors Multiples
Choom Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Choom Holdings Inc
CNSX:CHOO
2.3m CAD 0.1 -0.1 -9 -2.7
US
Eli Lilly and Co
NYSE:LLY
942.9B USD 15.8 51.1 34.4 36.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
488B USD 5.3 19.4 15.9 20.6
CH
Roche Holding AG
SIX:ROG
252.8B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP 4.8 29.9 108.2 158.3
CH
Novartis AG
SIX:NOVN
206.2B CHF 4.6 17.8 11.3 14.6
US
Merck & Co Inc
NYSE:MRK
247.4B USD 3.9 13 9.3 11
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.8 9.1 10.5
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
148.6B USD 2.4 15.1 7.7 10.5
P/E Multiple
Earnings Growth PEG
CA
C
Choom Holdings Inc
CNSX:CHOO
Average P/E: 23.2
Negative Multiple: -0.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
51.1
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.4
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.9
38%
0.8
CH
Novartis AG
SIX:NOVN
17.8
17%
1
US
Merck & Co Inc
NYSE:MRK
13
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
4%
3.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
15.1
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
C
Choom Holdings Inc
CNSX:CHOO
Average EV/EBITDA: 437.5
Negative Multiple: -9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.4
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
15.9
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.2
10%
10.8
CH
Novartis AG
SIX:NOVN
11.3
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.1
2%
4.5
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.7
1%
7.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
C
Choom Holdings Inc
CNSX:CHOO
Average EV/EBIT: 1 878.4
Negative Multiple: -2.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.9
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.6
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.6
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.5
1%
10.5
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.5
8%
1.3